Synchronous and Multiple Renal Cell Carcinoma, Clear Cell and Papillary: An Approach to Clinically Significant Genetic Abnormalities

Overview

Journal Int Braz J Urol

Specialty Urology

Date 2020 Feb 6

PMID 32022527

Citations 1

Authors

Laura Cifuentes-C

Carlos Humberto Martinez

Herney Andres Garcia-Perdomo

Affiliations

Soon will be listed here.

Citing Articles

Renal collision tumours: three additional case reports.

Belle Mbou V, Sanglier F, Pestre-Munier J, Descazeaud A, Labrousse F BMC Urol. 2022; 22(1):113.

PMID: 35870918 PMC: 9308929. DOI: 10.1186/s12894-022-01063-y.

References

Lehtonen H . Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer. 2011; 10(2):397-411. DOI: 10.1007/s10689-011-9428-z. View

Zhu M, Wen X, Liu X, Wang Y, Liang C, Tu J . Association between 8q24 rs6983267 polymorphism and cancer susceptibility: a meta-analysis involving 170,737 subjects. Oncotarget. 2017; 8(34):57421-57439. PMC: 5593654. DOI: 10.18632/oncotarget.18960. View

Linehan W . Genetic basis of bilateral renal cancer: implications for evaluation and management. J Clin Oncol. 2009; 27(23):3731-3. PMC: 5036849. DOI: 10.1200/JCO.2009.23.0045. View

Cingoz S, van der Luijt R, Kurt E, Apaydin M, Akkol I, Heval Ozgen M . A novel missense mutation (N78D) in a family with von Hippel-Lindau disease with central nervous system haemangioblastomas, pancreatic and renal cysts. Fam Cancer. 2012; 12(1):111-7. DOI: 10.1007/s10689-012-9586-7. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Banks R, Tirukonda P, Taylor C, Hornigold N, Astuti D, Cohen D . Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. Cancer Res. 2006; 66(4):2000-11. DOI: 10.1158/0008-5472.CAN-05-3074. View

Thery J, Krieger S, Gaildrat P, Revillion F, Buisine M, Killian A . Contribution of bioinformatics predictions and functional splicing assays to the interpretation of unclassified variants of the BRCA genes. Eur J Hum Genet. 2011; 19(10):1052-8. PMC: 3190263. DOI: 10.1038/ejhg.2011.100. View

Riazalhosseini Y, Lathrop M . Precision medicine from the renal cancer genome. Nat Rev Nephrol. 2016; 12(11):655-666. DOI: 10.1038/nrneph.2016.133. View

Lopez V, Jorda E, Monteagudo C . [Birt-Hogg-Dubé syndrome: an update]. Actas Dermosifiliogr. 2011; 103(3):198-206. DOI: 10.1016/j.ad.2011.07.009. View

10.

Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T . A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res. 2008; 68(23):9982-6. DOI: 10.1158/0008-5472.CAN-08-1838. View

11.

Klatte T, Patard J, Wunderlich H, Goel R, Lam J, Junker K . Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol. 2007; 177(6):2081-6. DOI: 10.1016/j.juro.2007.01.122. View

12.

Toro J, Wei M, Glenn G, Weinreich M, Toure O, Vocke C . BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008; 45(6):321-31. PMC: 2564862. DOI: 10.1136/jmg.2007.054304. View

13.

Pavlovich C, Walther M, Eyler R, Hewitt S, Zbar B, Linehan W . Renal tumors in the Birt-Hogg-Dubé syndrome. Am J Surg Pathol. 2002; 26(12):1542-52. DOI: 10.1097/00000478-200212000-00002. View

14.

da Silva N, Gentle D, Hesson L, Morton D, Latif F, Maher E . Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. J Med Genet. 2003; 40(11):820-4. PMC: 1735328. DOI: 10.1136/jmg.40.11.820. View

15.

Bartram M, Mishra T, Reintjes N, Fabretti F, Gharbi H, Adam A . Characterization of a splice-site mutation in the tumor suppressor gene FLCN associated with renal cancer. BMC Med Genet. 2017; 18(1):53. PMC: 5429543. DOI: 10.1186/s12881-017-0416-5. View

16.

Mikhail M, Ng J, Mathew J, Koshy Z . Von Hippel Lindau disease: keep it in the family. BMJ Case Rep. 2012; 2012. PMC: 4544970. DOI: 10.1136/bcr-2012-007851. View

17.

Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N . Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol. 2010; 58(5):701-10. DOI: 10.1016/j.eururo.2010.08.031. View

18.

Shuch B, Amin A, Armstrong A, Eble J, Ficarra V, Lopez-Beltran A . Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol. 2014; 67(1):85-97. DOI: 10.1016/j.eururo.2014.04.029. View

19.

Moore L, Nickerson M, Brennan P, Toro J, Jaeger E, Rinsky J . Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet. 2011; 7(10):e1002312. PMC: 3192834. DOI: 10.1371/journal.pgen.1002312. View

20.

Nishii T, Tanabe M, Tanaka R, Matsuzawa T, Okudela K, Nozawa A . Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome. Pathol Int. 2013; 63(1):45-55. DOI: 10.1111/pin.12028. View